Looking for codes for the newly released Project Egoist? You've come to the right place. By using the codes we've found, you can boost your cash and spend it on Gacha for Emotes, MVP Animations, Goal ...

He alleged that at the airport, he and his family were guided to use the security check area that the staff uses because they had a four-month-old baby. Police on Tuesday have recorded a detailed ...

Artur is a copywriter and SEO specialist, as well as a small business owner. In his free time, he loves to play computer games and is glad that he was able to connect his professional career with his ...

Failures of code are seen not as malfunctions but as opportunities, where mutation becomes both survival and a path to the new. The multimedia project “Code Error” by JS Art Gallery participates in ...

Added new Project Blue Lock codes on October 10, 2025. Project Blue Lock is another fun soccer game, inspired by the ever-popular anime series Blue Lock. In the game, players form a team of five ...

A behind-the-scenes blog about research methods at Pew Research Center. For our latest findings, visit pewresearch.org. Every survey finding published by Pew Research ...

3rd October 2025: We added new Moto Trackday Project codes. Moto Trackday Project is a Roblox racing game where you’ll buy and upgrade your own motorcycle, drive it around a realistic city, and race ...

The UC Board of Regents approved a new building for Bakar Labs and the Innovative Genomics Institute, or IGI, at the northwest corner of UC Berkeley’s campus last week. The seven-story,169,000 ...

15th July 2025: We added new Project Egoist codes. Project Egoist is an anime-inspired Roblox game that should appeal to fans of experiences like Blue Lock Rivals and Azure Latch. As with those games, ...

AbbVie has acquired global rights to the lead pipeline asset of Ichnos Glenmark Innovation (IGI), the cancer and autoimmune disease candidate ISB 2001, now in development against multiple myeloma, ...

AbbVie has struck an immuno-oncology licensing agreement with IGI Therapeutics that is potentially worth more than $1.9 billion to the clinical-stage biotechnology company. AbbVie on Thursday said it ...

AbbVie has entered into a $1 billion licensing agreement with IGI Therapeutics SA for IGI's lead investigational drug for oncology and autoimmune diseases. The deal will give AbbVie exclusive rights ...